Dr. Cantley is credited with discovering a family of enzymes fundamental to understanding cancer. He currently is the William Bosworth Castle Chair in Medicine and professor of systems biology at Harvard and director of the Cancer Center and chief of the division of signal transduction at Beth Israel Deaconess Medical Center in Boston.
As director of the Cancer Center, Dr. Cantley will be in charge of developing the Center into a collaborative, multidisciplinary research enterprise focused on gathering Weill Cornell’s research expertise under one umbrella. The Center will first focus on colorectal, lung, melanoma and hematopoietic cancers.
More Articles on New York Hospital Executive Moves:
Auburn Community Hospital in New York Selects Patrick Facteau as CFO
Catholic Health System in New York Extends CEO Joe McDonald’s Contract
Lewis County General Hospital CFO Richard Lang Takes New Position
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
